Combination Immunotherapy Approaches in Metastatic Renal Cell Carcinoma with Favorable Risk Scores: A Meta-Analysis of Individual Patient Data - Quiz - MDSpire

Combination Immunotherapy Approaches in Metastatic Renal Cell Carcinoma with Favorable Risk Scores: A Meta-Analysis of Individual Patient Data

  • By

  • Mattia Alberto Di Civita

  • Daniele Marinelli

  • Valerio Marco Michetti

  • Adele Artemi

  • Andrea Ballario

  • Andrea Torchia

  • Laura Pappalardo

  • Martina Pecoraro

  • Iolanda Speranza

  • Alessandro Sciarra

  • Valeria Panebianco

  • Michela Roberto

  • Daniele Santini

  • January 8, 2026

  • 0 min

Share

Original Source(s)

Combination Immunotherapy Approaches in Metastatic Renal Cell Carcinoma with Favorable Risk Scores: A Meta-Analysis of Individual Patient Data

  • by Mattia Alberto Di Civita, Daniele Marinelli, Valerio Marco Michetti, Adele Artemi, Andrea Ballario, Andrea Torchia, Laura Pappalardo, Martina Pecoraro, Iolanda Speranza, Alessandro Sciarra, Valeria Panebianco, Michela Roberto, Daniele Santini

  • January 8, 2026

Related Content

Mortality Patterns in U.S. Patients with Kidney Malignancies: A Retrospective Analysis from 1999 to 2023

Correction: Study on the mechanism of 18β-glycyrrhetinic acid inhibiting the proliferation of renal cancer cells by inducing autophagy through the miR-27a-5p/LC3 axis

International metastatic renal cell carcinoma database consortium classification and regression tree analysis to characterize objective response rates to first line in metastatic renal cell carcinoma